FDA Drug Recalls

Recalls / Class II

Class IID-0099-2018

Product

Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47

Brand name
Levetiracetam
Generic name
Levetiracetam Oral
Active ingredient
Levetiracetam
Route
Oral
NDC
31722-574
FDA application
ANDA203052
Affected lot / code info
Lot # E170346, Exp 02/19

Why it was recalled

Presence of foreign substance (screw)

Recalling firm

Firm
Hetero Labs, Ltd. - Unit III
Manufacturer
Camber Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
Plot 22-110, Part Ii, Ida, Rangareddy, Jeedimetla, Hyderabad, N/A N/A, India

Distribution

Quantity
4050 bottles
Distribution pattern
NJ

Timeline

Recall initiated
2017-10-12
FDA classified
2017-11-29
Posted by FDA
2017-12-06
Terminated
2020-09-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0099-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Levetiracetam · FDA Drug Recalls